article thumbnail

San Diego Tallies 7 IPOs in Best Year For Market Debuts Since 2014

Xconomy

It’s next week or never (until 2019, that is) for two San Diego companies that have filed documents with securities regulators indicating plans to go public. Will “CBUS” and “SI” join “THOR” and “RMED”?

article thumbnail

HipGeo Launches Updated iPhone Travel Blogging App

socalTECH

Fullerton-based HipGeo , the location tracking and social sharing software developer headed by Rich Rygg, has launched a new iPhone app, looking to help users track, document, and share their travels. READ MORE>>.

Blogging 154
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Retro: My Favorite Blog Post on Raising VC

Both Sides of the Table

On December 2nd, 2006 I wrote the blog post published later in this post when I was CEO of startup Koral about my experiences in pitching VCs. After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. My blog was wiped out.

article thumbnail

Nuance Goes All-in on Speech Tech, Sells Document Business to Kofax

Xconomy

Nuance Communications is selling its document imaging division to Kofax for $400 million in cash, as Nuance’s new CEO narrows the company’s focus on its conversational artificial intelligence products and cloud-related technologies. The sector has seen some big deals lately, including a.

article thumbnail

Gary Hayslip on the City of San Diego as Cybersecurity Test Bed

Xconomy

When Xconomy convened a dinner discussion earlier this year that included prominent San Diego cybersecurity innovators, startup founders, and system administrators, I was stunned to learn that Gary Hayslip oversees an IT network that blocks an average of 800,000 cyber attacks a day. We are actively involved with all four companies.

article thumbnail

Poseida Therapeutics Prepares for IPO to Advance CAR-T Treatments

Xconomy

In documents filed with securities regulators Friday, the San Diego company set a preliminary IPO target of $115 million. Poseida Therapeutics, which is testing CAR-T cell therapies for blood-borne and solid tumor cancers, has laid the groundwork for an initial public offering.

article thumbnail

Synthorx Files for IPO to Advance Enhanced Cytokine Drugs

Xconomy

The San Diego-based company says it wants to use the proceeds to put its lead product candidate, an investigational cancer therapy that’s based on the drug interleukin-2 (IL-2), through dose escalation and expansion trials, and to develop products based on the same compound to treat autoimmune disorders.